Trending Now
Business
What To Expect From Halliburton Monday
Halliburton (HAL) reports Q3 earnings Monday. Analysts expect revenue of $5.35 billion and eps of $0.37. The revenue estimate implies 8% growth sequentially. Investors...
Trump Threatens To Suspend NFL Players Over Anthem Protests
The NFL season is starting again and players are still engaging in silent protest during the National Anthem. I understand some players knelt during...
Lifestyle today
Entertainment
Coronavirus Sinks General Electric’s Moat
The coronavirus has brought the U.S. economy to a practical standstill. That is not good for highly-indebted companies like General Electric (GE). The company...
UMBC – Can The ‘Fighting Stringer Bells’ Do It Again?
UMBC pulled off arguably the greatest upset in NCAA history Friday night. The number 16 seed dispatched one seed Virginia, making themselves the first...
Restasis Buyers Hit Allergan With An Anti-trust Lawsuit
Allergan (AGN) simply cannot escape patent drama related to its blockbuster dry eye drug Restasis. Restasis buyers recently hit Allergan with an anti-trust lawsuit,...
Why Fed Chairman Jerome Powell Will Not Hike Rates This Year
The Federal Reserve released the minutes from its January 30-31 Federal Open Market Committee meeting. The minutes were much-watched by financial markets, particularly on...
In Praising Trump, Mark Cuban Hates On Shock Exchange
The coronavirus and low oil prices have presented a dilemma Fed Chairman Jerome Powell cannot fix by simply printing money. You cannot current the...
Will BlackBerry’s Achilles’ Heal Reveal Itself?
BlackBerry (BB) reports quarterly earnings September 28th. Analysts expect revenue of $207.71 million and EPS of $0.01. The revenue estimate implies a 2% decline...
Damian Lillard Researched Shock Exchange For NBA All Star Weekend Rap Performance
Damian Lillard, AKA Dame D.O.L.L.A. is considered one of the best rappers in the NBA, if not the very best. I first heard D.O.L.L.A. on...
Mylan Calls Allergan’s Mohawk Deal A ‘Sham’
Allergan (AGN) is suing generic drug makers Mylan (MYL) and Teva (TEVA) for patent infringement pursuant to Restasis, its blockbuster dry eye treatment. An...























































































































